Cite
APA Citation
Yu, K., Mantha, S., Tjan, C., Kaufmann, E., Brenner, R. B., Lowery, M., Ku, G., Raj, N., Shcherba, M., Goldberg, Z., Li, J., Zervoudakis, A., Hamilton, A., Won, E., Do, R. K. G., & O'Reilly, E. M. (n.d.). 730PA pilot study of gemcitabine, nab-paclitaxel, PEGPH20 (PAG) and rivaroxaban for advanced pancreatic adenocarcinoma: Interim safety and efficacy analysis. Annals of oncology, 29, . http://access.bl.uk/ark:/81055/vdc_100095200661.0x00003c